CSL presents new research and development center in Marburg, Germany
MARBURG, Germany, Sept. 13, 2022 /PRNewswire/ -- After three years of construction, global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY), today, inaugurated its new EUR 150 million research and development (R&D) site on the grounds of the research campus in Marburg's Görzhausen Industrial Park. Covering around 40,000 square meters, the M600 R&D center provides space for up to 500 R&D employees, making it CSL's largest R&D center worldwide and combining all disciplines under one roof.
- MARBURG, Germany, Sept. 13, 2022 /PRNewswire/ -- After three years of construction, global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY), today, inaugurated its new EUR 150 million research and development (R&D) site on the grounds of the research campus in Marburg's Grzhausen Industrial Park.
- Construction of CSL's new M600 research and development (R&D) center in Marburg, Germany, began in November 2019 and will be completed later this calendar year.
- It will also provide space for around 500 CSL research and development employees as well as academic and cooperation partners.
- Today, CSL including our three businesses, CSL Behring, CSL Seqirus, and CSL Vifor provides lifesaving products to patients in more than 100 countries and employs more than 30,000 people.